Products for Research Use Only
RegisterLogin

Gantenerumab Biosimilar - Research Grade

CAT: 1148-ICH5009-5mgSize: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1148-ICH5009-5mgSize:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Background
RUO gantenerumab is a monoclonal antibody for the treatment of Alzheimer’s disease being developed by Hoffmann-La Roche pharmaceuticals. Gantenerumab binds to and clears aggregated beta amyloid fibers. A phase III clinical trial of gantenerumab was stopped early because of a lack efficacy.
Specifications
Detects human Beta Amyloid. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Gantenerumab.
UniProt
P05067
Species Reactivity
Human
Target
Beta Amyloid
Isotype
IgG1
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Isotype Control
https://ichor.bio/product/bulk-human-igg1-isotype-control-ib1-ich2254/

UniProtKB · P05067

Amyloid-beta precursor protein

A4_HUMAN · Homo sapiens

View on UniProt ↗
Primary accession
P05067
Review status
UniProtKB reviewed (Swiss-Prot)
Gene
APP
Protein existence
1: Evidence at protein level
Organism
Homo sapiens (Human)
Taxonomy ID
9606
Alternative names
APP
EC number
—
Processing
Precursor
Secondary accessions
B2R5V1, B4DII8, D3DSD1, D3DSD2, D3DSD3, P09000, P78438, Q13764, Q13778, Q13793, Q16011, Q16014, Q16019, Q16020, Q6GSC0, Q8WZ99, Q9BT38, Q9UC33, Q9UCA9, Q9UCB6, Q9UCC8, Q9UCD1, Q9UQ58
Protein keywords

Technical term

3D-structureDirect protein sequencingProteomics identificationReference proteome

Coding sequence diversity

Alternative splicing

Disease

Alzheimer diseaseAmyloidosisDisease variantNeurodegeneration

Cellular component

AmyloidCell membraneCell projectionCoated pitCytoplasmCytoplasmic vesicleEndoplasmic reticulumEndosomeGolgi apparatusMembraneNucleusSecreted

Biological process

ApoptosisCell adhesionEndocytosisNotch signaling pathway

Ligand

CopperIronMetal-bindingZinc

PTM

Disulfide bondGlycoproteinIsopeptide bondOxidationPhosphoproteinProteoglycanSulfationUbl conjugation

Molecular function

Heparin-bindingProtease inhibitorSerine protease inhibitor

Domain

SignalTransmembraneTransmembrane helix

Related Products

CatalogName
ICH6018-0.1mgFeladilimab Biosimilar - Research Grade
ICH6017-5mgSonesitatug Biosimilar - Research Grade
ICH6017-100mgSonesitatug Biosimilar - Research Grade
ICH6016-10mgRilvegostomig Biosimilar - Research Grade
ICH6015-1mgIvonescimab Biosimilar - Research Grade
ICH6015-10mgIvonescimab Biosimilar - Research Grade
ICH6014-25mgIzalontamab Biosimilar - Research Grade
ICH6013-1mgZenocutuzumab Biosimilar - Research Grade
ICH6005-25mgZelminemab Biosimilar - Research Grade
ICH6002-25mgZanidatamab Biosimilar - Research Grade

Alternative Products

CatalogName
MBS3030371-01Gantenerumab Biosimilar - Research Grade
ABS-145-1mgGantenerumab Biosimilar, Research Grade
WA2897Research Grade Gantenerumab
10-244Gantenerumab (APP /Abeta42/Abeta40) - Research Grade Biosimilar
GTR18117539Gantenerumab (APP /Abeta42/Abeta40) - Research Grade Biosimilar Antibody
PX-TA1158-1MGGantenerumab Biosimilar - Anti-APP , Abeta42, Abeta40 mAb - Research Grade
ABS-241-100ugRefanezumab Biosimilar, Research Grade
MBS3030438-01Iratumumab Biosimilar - Research Grade
MBS3030590-01Efgartigimod Biosimilar - Research Grade
MBS3030583-01Ganitumab Biosimilar - Research Grade

Popular Products